People · Operator
Named in public records as an officer, director or promoter · active 2008–2025 · Biotechnology, Other, Other Energy, Retailing, Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Prolacta Bioscience Inc | — | Biotechnology | Series B | $64.7M | $353.6M | 2016 |
| Predixion Software, Inc. | — | Other | Series A | $28.2M | $60.9M | 2013 |
| Zadspace Inc | — | Other | Series A | $18.3M | $13.9M | 2008 |
| Hixwood CFS Partners, LLC | — | Other Energy | Series A | $12.6M | $43.1M | 2025 |
| Marval Biosciences Inc | — | Biotechnology | Seed | $6.5M | $111.0M | 2011 |
| Good Dye Young, Inc. | — | Retailing | Seed | $4.6M | $10.4M | 2016 |
| Chimeros Inc | — | Other Health Care | Pre-Seed | $4.1M | $11.6M | 2009 |
| Boka Sciences, Inc. | — | Other Technology | Seed | $2.1M | $35.8M | 2008 |
| Elteve, Inc. | — | Other | Seed | $1.7M | $11.6M | 2023 |
| Edufii, Inc. | — | Other Technology | Seed | $1.7M | $6.6M | 2014 |
| Swink, Inc. | — | Other | Pre-Seed | $1.2M | $17.3M | 2011 |
| DX Biosciences, Inc. | — | Other | Pre-Seed | $829K | $12.2M | 2010 |
Frank Foster at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Frank Foster on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dan Watkins | 2 | 8 |
| Stephen Watkins | 2 | 4 |
| Russell Lebovitz | 2 | 3 |
| Frank D. Foster | 2 | 2 |
| Robert Langer | 1 | 36 |
| Rick Smith | 1 | 14 |
| Allen DeBevoise | 1 | 14 |
| Greg Williams | 1 | 11 |
| Stuart Frost | 1 | 10 |
| Kent Madsen | 1 | 7 |
| John Shields | 1 | 6 |
| Pauline Murphy | 1 | 6 |
| Ilan Zipkin | 1 | 6 |
| James Ho | 1 | 6 |
| Stephen Chang | 1 | 5 |
| John Mendlein | 1 | 4 |
| Samir Mitragotri | 1 | 4 |
| David Brailer | 1 | 4 |
| Dan Janney | 1 | 4 |
| Miguel De Los Rios | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.